Literature DB >> 26902227

Breath Testing for Small Intestinal Bacterial Overgrowth: Should We Bother?

Mark Pimentel1.   

Abstract

The hydrogen breath test is based on following breath hydrogen levels after the administration of a carbohydrate (most commonly lactulose) to a patient with suspected small intestinal bacterial overgrowth. The test is based on the interaction between the administered carbohydrate and the intestinal bacteria. The resulting fermentation produces hydrogen. A positive breath test is based on a breath hydrogen rise prior to the expected arrival time in the highly microbial cecum. Despite renewed enthusiasm for breath testing in recent years due to associations with conditions such as irritable bowel syndrome, breath testing poses many challenges. In this argument against breath testing, several pitfalls that complicate breath testing will be described.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26902227     DOI: 10.1038/ajg.2016.30

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  8 in total

Review 1.  A systematic review of diagnostic tests for small intestinal bacterial overgrowth.

Authors:  Reza Khoshini; Sun-Chuan Dai; Sheila Lezcano; Mark Pimentel
Journal:  Dig Dis Sci       Date:  2008-06       Impact factor: 3.199

2.  Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference.

Authors:  A Gasbarrini; G R Corazza; G Gasbarrini; M Montalto; M Di Stefano; G Basilisco; A Parodi; P Usai-Satta; P U Satta; P Vernia; C Anania; M Astegiano; G Barbara; L Benini; P Bonazzi; G Capurso; M Certo; A Colecchia; L Cuoco; A Di Sario; D Festi; C Lauritano; E Miceli; G Nardone; F Perri; P Portincasa; R Risicato; M Sorge; A Tursi
Journal:  Aliment Pharmacol Ther       Date:  2009-03-30       Impact factor: 8.171

3.  Comparison of scintigraphy and lactulose breath hydrogen test for assessment of orocecal transit: lactulose accelerates small bowel transit.

Authors:  M A Miller; H P Parkman; J L Urbain; K L Brown; D J Donahue; L C Knight; A H Maurer; R S Fisher
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

4.  Rifaximin therapy for patients with irritable bowel syndrome without constipation.

Authors:  Mark Pimentel; Anthony Lembo; William D Chey; Salam Zakko; Yehuda Ringel; Jing Yu; Shadreck M Mareya; Audrey L Shaw; Enoch Bortey; William P Forbes
Journal:  N Engl J Med       Date:  2011-01-06       Impact factor: 91.245

5.  Antibiotic treatment of constipation-predominant irritable bowel syndrome.

Authors:  Mark Pimentel; Christopher Chang; Kathleen Shari Chua; James Mirocha; John DiBaise; Satish Rao; Meridythe Amichai
Journal:  Dig Dis Sci       Date:  2014-05-01       Impact factor: 3.199

6.  Methanogenic flora is associated with altered colonic transit but not stool characteristics in constipation without IBS.

Authors:  Ashok Attaluri; Michelle Jackson; Jessica Valestin; Satish S C Rao
Journal:  Am J Gastroenterol       Date:  2009-12-01       Impact factor: 10.864

7.  New and Emerging Treatment Options for Irritable Bowel Syndrome.

Authors:  Brian E Lacy; William D Chey; Anthony J Lembo
Journal:  Gastroenterol Hepatol (N Y)       Date:  2015-04

8.  Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.

Authors:  Mark Pimentel; Walter Morales; Ali Rezaie; Emily Marsh; Anthony Lembo; James Mirocha; Daniel A Leffler; Zachary Marsh; Stacy Weitsman; Kathleen S Chua; Gillian M Barlow; Enoch Bortey; William Forbes; Allen Yu; Christopher Chang
Journal:  PLoS One       Date:  2015-05-13       Impact factor: 3.240

  8 in total
  11 in total

1.  It is Time to Re-Think the Role of Small Intestinal Bacterial Overgrowth in IBS Patients.

Authors:  Edoardo Savarino; Manuele Furnari; Andrea Ottonello; Vincenzo Savarino
Journal:  Am J Gastroenterol       Date:  2016-09       Impact factor: 10.864

Review 2.  Diabetes and the Small Intestine.

Authors:  Jonathan Gotfried; Stephen Priest; Ron Schey
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

3.  Testing and Treating Small Intestinal Bacterial Overgrowth Reduces Symptoms in Patients with Inflammatory Bowel Disease.

Authors:  Shirley Cohen-Mekelburg; Zaid Tafesh; Elliot Coburn; Russell Weg; Neena Malik; Colleen Webb; Hoda Hammad; Ellen Scherl; Brian P Bosworth
Journal:  Dig Dis Sci       Date:  2018-05-14       Impact factor: 3.199

4.  Association of Presenting Symptoms With Abnormal Laboratory Values for Vector-Borne Illness - Experience in an Urban Gastroenterology Practice.

Authors:  Michael D Erdman; Niloofar Kossari; Jessica Ye; Kristen H Reynolds; Emily Blodget; B Robert Mozayeni; Farshid Sam Rahbar
Journal:  J Patient Cent Res Rev       Date:  2021-01-19

5.  Reevaluating our understanding of lactulose breath tests by incorporating hydrogen sulfide measurements.

Authors:  Aleksandr Birg; Steve Hu; Henry C Lin
Journal:  JGH Open       Date:  2019-02-22

Review 6.  Gastrointestinal motility and absorptive disorders in patients with inflammatory bowel diseases: Prevalence, diagnosis and treatment.

Authors:  Luísa Leite Barros; Alberto Queiroz Farias; Ali Rezaie
Journal:  World J Gastroenterol       Date:  2019-08-21       Impact factor: 5.742

Review 7.  Small Intestinal Bacterial Overgrowth in Children: A State-Of-The-Art Review.

Authors:  David Avelar Rodriguez; Paul MacDaragh Ryan; Erick Manuel Toro Monjaraz; Jaime Alfonso Ramirez Mayans; Eamonn Martin Quigley
Journal:  Front Pediatr       Date:  2019-09-04       Impact factor: 3.418

8.  Small intestinal bacterial overgrowth in children with intestinal failure on home parenteral nutrition.

Authors:  Kathleen H McGrath; James Pitt; Julie E Bines
Journal:  JGH Open       Date:  2019-04-04

9.  Non-invasive continuous real-time in vivo analysis of microbial hydrogen production shows adaptation to fermentable carbohydrates in mice.

Authors:  José M S Fernández-Calleja; Prokopis Konstanti; Hans J M Swarts; Lianne M S Bouwman; Vicenta Garcia-Campayo; Nils Billecke; Annemarie Oosting; Hauke Smidt; Jaap Keijer; Evert M van Schothorst
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

10.  Serotonin Pathway of Tryptophan Metabolism in Small Intestinal Bacterial Overgrowth-A Pilot Study with Patients Diagnosed with Lactulose Hydrogen Breath Test and Treated with Rifaximin.

Authors:  Cezary Chojnacki; Tomasz Popławski; Paulina Konrad; Michal Fila; Jan Chojnacki; Janusz Błasiak
Journal:  J Clin Med       Date:  2021-05-12       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.